Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wayne, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Aclaris Therapeutics, Inc. has filed 849 SEC EDGAR filings since 10 Sep 2012

SEC filing history

Showing 76-100 of 149 matching filings.

Per page
25
Current page
4
8-K File 001-37581

8-K

Filing date
27 May 2020
Reporting date
27 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
15 May 2020
Reporting date
15 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
07 May 2020
Reporting date
07 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
31 Mar 2020
Reporting date
30 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

FORM 8-K

Filing date
13 Mar 2020
Reporting date
13 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
25 Feb 2020
Reporting date
25 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
13 Jan 2020
Reporting date
13 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
08 Jan 2020
Reporting date
07 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
03 Dec 2019
Reporting date
02 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
21 Nov 2019
Reporting date
21 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
07 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
17 Oct 2019
Reporting date
15 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
11 Oct 2019
Reporting date
10 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
27 Sep 2019
Reporting date
27 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
09 Sep 2019
Reporting date
03 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
05 Sep 2019
Reporting date
03 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
08 Aug 2019
Reporting date
08 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
30 Jul 2019
Reporting date
30 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
03 Jul 2019
Reporting date
02 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
17 Jun 2019
Reporting date
17 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
07 Jun 2019
Reporting date
06 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
05 Jun 2019
Reporting date
05 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
08 May 2019
Reporting date
08 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
04 Apr 2019
Reporting date
04 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37581

8-K

Filing date
18 Mar 2019
Reporting date
18 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .